Optimizing Cardiovascular Gene Therapy

Optimizing cardiovascular risk reduction during antihypertensive therapy.

Over the past decade, pharmacological treatment of elevated blood pressure has evolved from empiricism to a more individualized approach based on patient characteristics and an expanding understanding of the impact of specific agents on the pathophysiology of hypertension and, more importantly, cardiovascular disease. Although blood pressure elevation has been shown to be a powerful risk factor...

gene therapy in cardiovascular research

cardiovascular gene therapy: advances and challenges

-

Gene Therapy for Cardiovascular Disease

The last decade has seen substantial advances in the development of gene therapy strategies and vector technology for the treatment of a diverse number of diseases, with a view to translating the successes observed in animal models into the clinic. Perhaps the overwhelming drive for the increase in vascular gene transfer studies is the current lack of successful long-term pharmacological treatm...

Gene Therapy in Cardiovascular Research

* Corresponding author: Arpad Tosaki, Department of Pharmacology, Faculty of Pharmacy, Health and Science Center, University of Debrecen, Debrecen, Hungary, Tel/Fax: +36-52-255586, E-mail: [email protected] © 2012 School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences; Published by DocS. This is an Open Access article distributed under the terms of the Creative Commons ...